Vaccination of 27- to 45-Year-Olds Against HPV Is Less Cost-Effective
TUESDAY, Nov. 26, 2024 (HealthDay News) -- Vaccination of 27- to 45-year-olds ("mid-adults") against human papillomavirus (HPV) is less cost-effective than vaccination of younger persons (a...